Calithera Biosciences, Inc.
CONJOINT THERAPY WITH GLUTAMINASE INHIBITORS

Last updated:

Abstract:

The invention relates to methods of treating cancer using novel heterocyclic glutaminase inhibitor compounds conjointly with a PD1 or PD-L1 inhibitor.

Status:
Application
Type:

Utility

Filling date:

1 Nov 2018

Issue date:

17 Jun 2021